EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells

Roberto Donini iD, Pat Blundell iD, Richard J Pleass iD, Dongli Lu, Anne Dell iD, Cleo Kontoravdi iD, Stuart M Haslam iD

Biotechnology and Bioengineering · 2025

DOI: 10.1002/bit.70045 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2025. Written by Roberto Donini and 6 co-authors. Institution: Department of Life Sciences, Imperial College London, London, UK. Major MEDLINE topics: Polysaccharides, Genetic Variation. Cited 4 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, R.D. thanks the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) for their PhD studentship (BB/M011178/1). R.J.P. was funded by a Wellcome T….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

While Chinese hamster ovary (CHO) cells continue to be the workhorse of recombinant therapeutic protein production, decades of genetic divergence in the industrially relevant CHO‐K1 and CHO‐S cell lines, are likely to have resulted in differing glycosylation capabilities. Glycosylation can influence the efficacy, serum half‐life, and safety of biologics, and as a critical quality attribute of glycoprotein biopharmaceuticals, it is essential to better understand how major CHO cell manufacturing platforms diverge. We used matrix‐assisted laser desorption ionization‐time of flight mass spectrometry to perform N‐glycomic analyses comparing CHO‐K1 cells, CHO‐S cells and antibody‐producing daughter cell lines. The results reveal that genetic divergence in these industrially relevant cell lines, as well as the burden of antibody production, lead to significant differences in antennal branching and terminal elaboration in the cellular N‐glycome. More specifically, CHO‐K1 cells produce larger and more complex N‐glycans with higher levels of sialylation than CHO‐S cells, and antibody production was associated with increased antennal branching. Additionally, these findings were also reflected in the N‐glycomic profiles of IgG1‐Fc constructs produced in either CHO‐K1 and CHO‐S cells.

Subjects

MeSH terms (MEDLINE)

PolysaccharidesGenetic VariationAnimalsCHO CellsCricetulusGlycosylationRecombinant ProteinsCricetinaeGlycomics

Author keywords

Chinese hamster ovary (CHO) cellsMALDI‐TOFN‐glycosylationantibody glycoengineeringbiopharmaceuticalsmass spectrometry

Substances

Recombinant ProteinsPolysaccharides

Authors and institutions

  • Department of Life Sciences, Imperial College London, London, UK.
  • Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Department of Chemical Engineering, Imperial College London, London, UK.

ORCID profiles: Roberto Donini, Pat Blundell, Richard J Pleass, Anne Dell, Cleo Kontoravdi, Stuart M Haslam

Funding

  • Wellcome Trust
  • R.D. thanks the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) for their PhD studentship (BB/M011178/1). R.J.P. was funded by a Wellcome T…

Cite

APA

Donini, R., Blundell, P., Pleass, R. J., Lu, D., Dell, A., Kontoravdi, C., & Haslam, S. M. (2025). Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70045

Vancouver

Donini R, Blundell P, Pleass RJ, Lu D, Dell A, Kontoravdi C, et al. Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.70045

BibTeX
@article{Donini2025,
  author = {Donini, Roberto and Blundell, Pat and Pleass, Richard J and Lu, Dongli and Dell, Anne and Kontoravdi, Cleo and Haslam, Stuart M},
  title = {Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  doi = {10.1002/bit.70045}
}
Start for free →